GeneNews Limited announced the appointment of Dr; Joel V. Brill, MD as the Chief Medical Officer of its Innovative Diagnostic Laboratory, LLP joint-venture. In his new role, Dr. Brill will assume leadership responsibility for the medical aspects of IDL's laboratory, and act as the company's medical lead with physicians, patients and insurance providers. Dr. Brill will serve on IDL's executive committee as its medical representative, providing strategic counsel on current and new products, the identification of new technologies, and reimbursement issues.

Dr. Brill is an executive clinician with 30 years of experience providing strategic leadership and medical oversight to data-driven health organizations, skilled in strategy, development and implementation of innovative health programs, products and payment systems, with extensive experience in clinical practice and research.